SC 13D

Company

REGENXBIO Inc.

Filed

September 25, 2015

Accession Number

0001193125-15-329254

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →